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ABSTRACT 
Background: During a period from January to March 2005, there was a sud- 
den 3.85-fold increase in isolates with in vitro resistance to amoxicillin/clavulanic 
acid at Sant Parmanand Hospital, a private tertiary care hospital in Delhi, India, 
without an increase in treatment failures. 
Objective: This pilot study was designed to assess whether 2 different 
brands (one exclusively used during the last quarter of 2004, one exclusively 
used during the first quarter of 2005) of antibiotic disks used at the hospital 
were related to the reported change in resistance pattern. 
Methods: During April 2005, 50 consecutive hospital isolates, 45 gram negative 
and 5 gram positive, were tested in parallel, employing 2 brands of amoxicillin/ 
clavulanic acid disks: HiMedia disks (HiMedia Laboratories, Mumbai, India) 
and BBLTMSensi-DiscTMAntimicrobial Susceptibility Test Discs (BD Diagnostic 
Systems, Sparks, Maryland). 
Results: Of 50 consecutive hospital isolates tested with the HiMedia disks, 
40 were resistant and 10 were susceptible. Of those tested with the BBL disks, 
10 were resistant and 40 were susceptible. The susceptibility profiles observed 
were significantly different (P < 0.001). 
Conclusion: In this study, significantly different susceptibility results were 
found when 2 different brands of antibiotic disks were used to test the amoxicillin/ 
clavulanic susceptibility of 50 consecutive isolates in this private hospital 
in India. (Curr Ther Res Clin Exp. 2006;67:151-156) Copyright © 2006 Excerpta 
Medica, Inc. 
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INTRODUCTION 
In vitro assays of bacterial isolates derived from clinical material help to deter- 
mine antimicrobial susceptibility profiles. This process can assist clinicians in 
discovering the most efficient combination of antimicrobials required for treat- 
ment. Reliability and accuracy of the resultant assay profiles are related to the 
technology employed, including disks that incorporate various antibiotics. The 
poor quality of test reports from diagnostic laboratories, regardless of geo- 
graphic location, has been a cause for alarm. 1
A pilot attempt o monitor the emergence and dissemination of multidrug- 
resistant bacteria has been ongoing at the Sant Parmanand Hospital, a 140-bed 
private tertiary care facility in Delhi, India. The retrospective susceptibility pro- 
file of bacterial isolates from outpatients and inpatients was used to select he 
most promising antimicrobials for prospective therapeutic treatment. 2 During the 
final quarter of 2004, 197 isolates from were assessed. Of these, 156 were suscep- 
tible and 41 were resistant to amoxicillin/clavulanic acid. 2 However, in the first 
quarter of 2005, poor susceptibility (based on MIC values ranging from ___4/2- 
___8/4 1Jg/mL) was noted for several antimicrobials, including [3-1actam/[3-1actamase 
inhibitors, cephalosporins, aminoglycosides, and a glycopeptide. During that 
time, of 215 assessed isolates, 48 appeared susceptible and 167 appeared re- 
sistant. The susceptibility data from the 2 quarters were significantly different 
(P < 0.001). 
We conducted a pilot study to compare the susceptibility to amoxicillin/ 
clavulanic acid in 50 isolates using the 2 antibiotic disks employed in our 
institution. 
MATERIALS AND METHODS 
During April 2005, 50 successive isolates (45 gram negative and 5 gram positive) 
from different sites of infection were scrutinized in parallel using suscepti- 
bility disks from 2 manufacturers: HiMedia* disks and BBL TM Sensi-Disc TM 
Antimicrobial Susceptibility Test Discs. T Neither disks were used simultaneous- 
ly. HiMedia disk usage was from January 1, 2005, to May 17, 2005. Previously and 
consequently BBL disks were employed. Specimens were cultured immediately 
on receipt in the laboratory on MacConkey's agar, blood agar, chocolate agar, 
and Mannitol salt agar plates. After 24 to 48 hours of incubation at 37°C, 
colonies were identified using morphology, biochemical characters, and/or 
slide agglutination. Tests were performed by the same set of personnel. Disks 
were stored at 4°C and used before their respective xpiration dates. HiMedia 
recommends storage of their disks between 2°C and 8°C, while BBL disks should 
be stored between -20°C and 8°C. They were labeled with 20 1Jg amoxicillin and 
10 1Jg clavulanic acid. Susceptibility assays were performed on Mueller-Hinton 
plates using the agar diffusion technique. 
*Trademark of HiMedia Laboratories, Mumbai, India. 
tTrademark of BD Diagnostic Systems, Sparks, Maryland. 
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Statistical Analysis 
The significance of differences found in susceptibi l ity values was determined 
using the Fisher exact probabil ity test. Statistical analyses were performed on- 
line using Simple Interactive Statistical Analysis (http://home.clara.net/sisa), a 
form-based statistical analysis service. No power analysis was done. The num- 
ber of isolates tested (50) was chosen due to convenience. 
RESULTS 
Of the 50 parallel isolates tested, there were 30 isolates of Escherichia coli, 9 of 
Klebsiella, 5 of Staphylococcus aureus (MIC ___4/2 pg/mL), and 2 isolates each of 
Proteus, Pseudomonas, and Salmonella typhi (MIC ___8/4 pg/mL). Among E coli, the 
numbers of resistant isolates reported with the HiMedia and BBL disks were 27 
and 6, respectively, with related susceptibi l ity values of 3 and 24 (Table I). With 
Klebsiella, as against 2 susceptible and 7 resistant with the HiMedia disks, the 
respective BBL values were 7 and 2. For S aureus, there were 3 sensitive and 2 
resistant isolates with the HiMedia disks, but they were all susceptible on test- 
ing with the BBL disks. Both Pseudomonas i olates were uniformly resistant. For 
both Proteus and S typhi, 1 out of 2 HiMedia disks were susceptible, whereas 
with the BBL disks, all 4 were susceptible. In aggregate, employing the BBL 
disks resulted in 40 susceptible and 10 resistant isolates, whereas testing with 
the HiMedia disks found 10 susceptible and 40 resistant isolates (P < 0.001). 
DISCUSSION 
The increase in antimicrobial resistance witnessed in our institution during the 
first quarter of 2005 was alarming. Within 3 months, the amoxicill in/clavulanic 
acid resistance pattern had reversed. No change in personnel or premises had 
Table I. Susceptibility results from 50 successive isolates derived from different sites 
of infection using 2 types of antibiotic disks. 
Bacteria 
Susceptible Isolates Susceptible Isolates 
Isolates, HiMedia disks,* BBL TM Sensi-DiscTM, t 
no. (%) no. (%) no. (%) 
(N = 50) (n = 10) (n = 40) 
Escherichia coil 30 (60) 3 (30) 24 (80) 
Klebsiella 9 (18) 2 (20) 7 (1 7.5) 
Staphylococcus aureus 5 (10) 3 (30) 5 (12.5) 
Proteus 2 (4) 1 (10) 2 (5) 
Pseudomonas 2 (4) 0 0 
Salmonella typhi 2 (4) 1 (10) 2 (5) 
*Trademark of HiMedia Laboratories, Mumbai, India. 
tTrademark of BD Diagnostic Systems, Sparks, Maryland. 
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occurred, nor were any clinical amoxicillin/clavulanic acid failures reported in 
patients. The antimicrobial disks used were procured from 2 sources: BBL disks 
were used in 2004 and HiMedia disks were used from January to May 2005. Each 
disk contained 20 1Jg amoxicillin and 10 1Jg clavulanic acid. Disks were stored at 
4°C and used before their expiration dates. 
Since October 2004, our hospital has created quarterly computerized pro- 
files of antimicrobial isolates exhibiting ---75% susceptibility in vitro, grouped 
by clinical profile. Between October and December 2004, amoxicillin/clavulanic 
acid was one of the antibiotics to which E coli, Klebsiella, S aureus, Proteus, 
Pseudomonas, and S typhi were susceptible (Table If). Of the 197 isolates as- 
sessed, 156 were susceptible and 41 were resistant to amoxicillin/clavulanic 
acid. 2 However, from January to March 2005, there was a reversal, with 48 suscep- 
tible and 167 resistant isolates. The susceptibility data from the 2 quarters were 
significantly different (P < 0.001). There were also statistically different suscepti- 
bility figures for cefaclor, cefotaxime, ceftazidime, kamamycin, and vancomycin. 
We hypothesize that clavulanic acid in the HiMedia disks might not have 
reflected the labeled concentration. Quantification of individual amoxicillin/ 
clavulanic acid disk components was not available in our hospital. 
Amoxicillin/clavulanic a id has become the most prescribed antibiotic in the 
West with the maximum susceptibility and minimal resistance values. 3 Irre- 
spective of amoxicillin/clavulanic susceptibility, hospital staphylococci are 
screened for methicillin-resistant S aureus. A switch from a [3-1actam to a non- 
[3-1actam antimicrobial ensured an effective response in 3 hospitalized cases. 4
Unfortunately, none of the 10 state-level academic linical microbiology lab- 
oratories in India have had adequate stock of the quality-control strains speci- 
fied by the NCCLS. 5 Lack of local NCCLS reference cultures of E coli American 
Type Culture Collection (ATCC) 25922, E coli ATCC 35218, Pseudomonas aerugi- 
nosa ATCC 27853, andSaureus ATCC 25923 and 29213 was a limitation. Scrutiny 
of the range of inhibition with amoxicillin/clavulanic a id and gram-negative 
and gram-positive ATCC cultures might have been useful for identifying defi- 
ciency in the disks. Even so, the quarterly analysis of in vitro susceptibility pro- 
files used in our facility was useful for detecting inconsistent results. Quality- 
control strains would help to identify deficient disks employed in health care 
laboratories. 
Other limitations of our pilot study include a lack of facilities for molecular 
studies on bacterial plasmid or chromosomal characters. Plasmids, such as 
mediated class A [3-1actamases and extended-spectrum [3-1actamases (ESBLs), 
occur in gram-negative bacteria. Furthermore, plasmids in some bacteria lso 
carry [3-1actamases derived from chromosomal class C [3-1actamases, the 
plasma-mediated cyclic adenosine monophosphate (cAMP) type [3-1actamases. 
Such strains have a resistance pattern similar to that of ESBLs, as do combina- 
tions of [3-1actam with [3-1actamase inhibitors and cefoxitin. Ten resistant isolates-- 
E coli (6), Klebsiella (2), and Pseudomonas (2)--merit molecular studies of 
their genetic omponents. Nonetheless, the hospital is searching for circulating 
154 
S.C. Arya et al. 
0 
0 
°~ 
c -  
O 
0 
tN  
U 
0 
0 
IN  
0 
°~ 
°~ 
°~ 
0 °~ 
°~ 
e-  
c-  
O 
0 
Q.~ .m 
C 
~ .>- 
.m 
C 
C 
~ '~)  
.=_< ~ 
X e~ 
d~ 
z% 
L- 
. ¢'~ 
0 ~"q r'm '..0 
oO oO 
oo ~ Vl ,,o oo Vl 
oo oo oo 
,.o a-, Vl oo o Vl a-, ,.o Vl 
CN ~ CN 
Vl Vl Vl Vl Vl 
oO r-~ m m b~ ~"~ oo O', c,4 O', 
oO oO 
O c,4 Vl ~ r,~ Vl 
E E 
~ Vl ~ ~ Vl 
~ Vl ~ ~ Vl o ~ Vl 
E E 
m ~ Vl ~ ~ Vl ~ ~ Vl 
O O O O 
O O O O ~ ° ~ ~ f'N f'N 
• .o ~ O 
oO 
~ Vl 
0 0 
-s 
kO 
vI 
CN 
E 
E -~ 
"~ 0 
t- 
O0 c"~ 
o ' ,m Vl ~ 
O c,4 "~ '~ 
~- -~.~ 
~o 
',D ~ VI Q. .~ 
,O  m..Q 
E~ ~---J 
m._  
~N 
C m 
~ m 
°i; 
155 
CURRENT THERAPEUTIC RESEARCH 
ESBL producers,  and investigations are planned to examine the effects of circu- 
lating ESBL producers in hospital patients. A study of the possible role of the 
cAMP gene encoding resistance was not conducted in this study. 
CONCLUSION 
In this study of 2 types of antibiotic disks used to test the amoxicill in/clavulanic 
acid susceptibi l ity of 50 consecutive isolates in a private hospital in India, sig- 
nificantly different susceptibi l ity results were found. 
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